Mesa Laboratories Statistics
Total Valuation
MLAB has a market cap or net worth of $489.11 million. The enterprise value is $642.24 million.
Important Dates
The next confirmed earnings date is Tuesday, February 3, 2026, before market open.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | Nov 28, 2025 |
Share Statistics
MLAB has 5.52 million shares outstanding. The number of shares has increased by 1.18% in one year.
| Current Share Class | 5.52M |
| Shares Outstanding | 5.52M |
| Shares Change (YoY) | +1.18% |
| Shares Change (QoQ) | -0.32% |
| Owned by Insiders (%) | 3.12% |
| Owned by Institutions (%) | 91.99% |
| Float | 5.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 69.22 |
| PS Ratio | 1.96 |
| Forward PS | 1.87 |
| PB Ratio | 2.71 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 13.04 |
| P/OCF Ratio | 11.87 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 16.12, with an EV/FCF ratio of 17.25.
| EV / Earnings | n/a |
| EV / Sales | 2.62 |
| EV / EBITDA | 16.12 |
| EV / EBIT | 42.71 |
| EV / FCF | 17.25 |
Financial Position
The company has a current ratio of 2.02, with a Debt / Equity ratio of 1.00.
| Current Ratio | 2.02 |
| Quick Ratio | 1.28 |
| Debt / Equity | 1.00 |
| Debt / EBITDA | 3.86 |
| Debt / FCF | 4.80 |
| Interest Coverage | 1.36 |
Financial Efficiency
Return on equity (ROE) is -0.92% and return on invested capital (ROIC) is 2.53%.
| Return on Equity (ROE) | -0.92% |
| Return on Assets (ROA) | 2.13% |
| Return on Invested Capital (ROIC) | 2.53% |
| Return on Capital Employed (ROCE) | 3.94% |
| Revenue Per Employee | $335,966 |
| Profits Per Employee | -$2,153 |
| Employee Count | 730 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 3.23 |
Taxes
In the past 12 months, MLAB has paid $8.83 million in taxes.
| Income Tax | 8.83M |
| Effective Tax Rate | 121.67% |
Stock Price Statistics
The stock price has decreased by -38.32% in the last 52 weeks. The beta is 0.89, so MLAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | -38.32% |
| 50-Day Moving Average | 77.94 |
| 200-Day Moving Average | 86.80 |
| Relative Strength Index (RSI) | 75.54 |
| Average Volume (20 Days) | 94,725 |
Short Selling Information
The latest short interest is 283,413, so 5.13% of the outstanding shares have been sold short.
| Short Interest | 283,413 |
| Short Previous Month | 280,290 |
| Short % of Shares Out | 5.13% |
| Short % of Float | 5.30% |
| Short Ratio (days to cover) | 1.59 |
Income Statement
In the last 12 months, MLAB had revenue of $245.26 million and -$1.57 million in losses. Loss per share was -$0.29.
| Revenue | 245.26M |
| Gross Profit | 152.44M |
| Operating Income | 15.04M |
| Pretax Income | 7.26M |
| Net Income | -1.57M |
| EBITDA | 39.84M |
| EBIT | 15.04M |
| Loss Per Share | -$0.29 |
Full Income StatementBalance Sheet
The company has $21.95 million in cash and $178.67 million in debt, with a net cash position of -$156.72 million or -$28.38 per share.
| Cash & Cash Equivalents | 21.95M |
| Total Debt | 178.67M |
| Net Cash | -156.72M |
| Net Cash Per Share | -$28.38 |
| Equity (Book Value) | 178.47M |
| Book Value Per Share | 32.39 |
| Working Capital | 49.14M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $40.91 million and capital expenditures -$3.67 million, giving a free cash flow of $37.24 million.
| Operating Cash Flow | 40.91M |
| Capital Expenditures | -3.67M |
| Free Cash Flow | 37.24M |
| FCF Per Share | $6.74 |
Full Cash Flow StatementMargins
Gross margin is 62.15%, with operating and profit margins of 6.13% and -0.64%.
| Gross Margin | 62.15% |
| Operating Margin | 6.13% |
| Pretax Margin | 2.96% |
| Profit Margin | -0.64% |
| EBITDA Margin | 16.24% |
| EBIT Margin | 6.13% |
| FCF Margin | 15.18% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 0.73%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 0.73% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.18% |
| Shareholder Yield | -0.45% |
| Earnings Yield | -0.32% |
| FCF Yield | 7.67% |
Dividend DetailsAnalyst Forecast
The average price target for MLAB is $83.00, which is -6.29% lower than the current price. The consensus rating is "Hold".
| Price Target | $83.00 |
| Price Target Difference | -6.29% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MLAB has an Altman Z-Score of 1.65 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.65 |
| Piotroski F-Score | 5 |
